Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018544486> ?p ?o ?g. }
- W2018544486 endingPage "768" @default.
- W2018544486 startingPage "762" @default.
- W2018544486 abstract "MicroRNAs (miRNAs) are small RNAs that control gene expression, and are involved in the regulation of fundamental biological processes including development, cell differentiation, proliferation, and apoptosis. miRNAs regulate gene expression in normal hematopoiesis, and aberrant miRNA expression might contribute to leukomogenesis. Specifically, miR-21 is abundantly expressed in various tumors including leukemia and lymphoma, and is functionally involved in oncogenic processes. We investigated a role for miR-21 in Sézary Syndrome (SS), a cutaneous T-cell lymphoma (CTCL) with CD4+ tumor cells (Sézary cells) present in the skin, lymph nodes, and peripheral blood. It was shown previously that SS is characterized by constitutively activated signal transducer and activator of transcription 3 (STAT3) signaling. In this study we show by chromatin immunoprecipitation that miR-21 is a direct STAT3 target in Sézary cells. Stimulation of Sézary cells or healthy CD4+ T cells with the common-γ chain cytokine IL-21 results in a strong activation of STAT3, and subsequent upregulation of miR-21 expression. Both pri- and mature miR-21 expression are increased in Sézary cells when compared with CD4+ T cells from healthy donors. Silencing of miR-21 in Sézary cells results in increased apoptosis, suggesting a functional role for miR-21 in the leukomogenic process. Consequently, miR-21 might represent a therapeutic target for the treatment of SS. MicroRNAs (miRNAs) are small RNAs that control gene expression, and are involved in the regulation of fundamental biological processes including development, cell differentiation, proliferation, and apoptosis. miRNAs regulate gene expression in normal hematopoiesis, and aberrant miRNA expression might contribute to leukomogenesis. Specifically, miR-21 is abundantly expressed in various tumors including leukemia and lymphoma, and is functionally involved in oncogenic processes. We investigated a role for miR-21 in Sézary Syndrome (SS), a cutaneous T-cell lymphoma (CTCL) with CD4+ tumor cells (Sézary cells) present in the skin, lymph nodes, and peripheral blood. It was shown previously that SS is characterized by constitutively activated signal transducer and activator of transcription 3 (STAT3) signaling. In this study we show by chromatin immunoprecipitation that miR-21 is a direct STAT3 target in Sézary cells. Stimulation of Sézary cells or healthy CD4+ T cells with the common-γ chain cytokine IL-21 results in a strong activation of STAT3, and subsequent upregulation of miR-21 expression. Both pri- and mature miR-21 expression are increased in Sézary cells when compared with CD4+ T cells from healthy donors. Silencing of miR-21 in Sézary cells results in increased apoptosis, suggesting a functional role for miR-21 in the leukomogenic process. Consequently, miR-21 might represent a therapeutic target for the treatment of SS. benign erythroderma chromatin immunoprecipitation cutaneous T-cell lymphoma cucurbitacin I microRNA phosphatase and tensin homolog Sézary Syndrome signal transducer and activator of transcription" @default.
- W2018544486 created "2016-06-24" @default.
- W2018544486 creator A5008094633 @default.
- W2018544486 creator A5032715968 @default.
- W2018544486 creator A5054635684 @default.
- W2018544486 creator A5056818066 @default.
- W2018544486 creator A5061789027 @default.
- W2018544486 creator A5064798164 @default.
- W2018544486 creator A5069079748 @default.
- W2018544486 creator A5075947127 @default.
- W2018544486 creator A5084429665 @default.
- W2018544486 date "2011-03-01" @default.
- W2018544486 modified "2023-10-16" @default.
- W2018544486 title "MicroRNA-21 Expression in CD4+ T Cells Is Regulated by STAT3 and Is Pathologically Involved in Sézary Syndrome" @default.
- W2018544486 cites W1548640328 @default.
- W2018544486 cites W1968843397 @default.
- W2018544486 cites W1969324239 @default.
- W2018544486 cites W1982541197 @default.
- W2018544486 cites W1990645475 @default.
- W2018544486 cites W1994216821 @default.
- W2018544486 cites W1999360191 @default.
- W2018544486 cites W2000093333 @default.
- W2018544486 cites W2004246503 @default.
- W2018544486 cites W2006379003 @default.
- W2018544486 cites W2007096007 @default.
- W2018544486 cites W2008955962 @default.
- W2018544486 cites W2010180766 @default.
- W2018544486 cites W2034985338 @default.
- W2018544486 cites W2056480903 @default.
- W2018544486 cites W2056723709 @default.
- W2018544486 cites W2067881481 @default.
- W2018544486 cites W2069104846 @default.
- W2018544486 cites W2069531817 @default.
- W2018544486 cites W2075340488 @default.
- W2018544486 cites W2083631019 @default.
- W2018544486 cites W2096160655 @default.
- W2018544486 cites W2103211592 @default.
- W2018544486 cites W2104610341 @default.
- W2018544486 cites W2110754651 @default.
- W2018544486 cites W2138864086 @default.
- W2018544486 cites W2162038712 @default.
- W2018544486 cites W2165460739 @default.
- W2018544486 cites W2302457562 @default.
- W2018544486 cites W4251765607 @default.
- W2018544486 doi "https://doi.org/10.1038/jid.2010.349" @default.
- W2018544486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21085192" @default.
- W2018544486 hasPublicationYear "2011" @default.
- W2018544486 type Work @default.
- W2018544486 sameAs 2018544486 @default.
- W2018544486 citedByCount "116" @default.
- W2018544486 countsByYear W20185444862012 @default.
- W2018544486 countsByYear W20185444862013 @default.
- W2018544486 countsByYear W20185444862014 @default.
- W2018544486 countsByYear W20185444862015 @default.
- W2018544486 countsByYear W20185444862016 @default.
- W2018544486 countsByYear W20185444862017 @default.
- W2018544486 countsByYear W20185444862018 @default.
- W2018544486 countsByYear W20185444862019 @default.
- W2018544486 countsByYear W20185444862020 @default.
- W2018544486 countsByYear W20185444862021 @default.
- W2018544486 countsByYear W20185444862022 @default.
- W2018544486 countsByYear W20185444862023 @default.
- W2018544486 crossrefType "journal-article" @default.
- W2018544486 hasAuthorship W2018544486A5008094633 @default.
- W2018544486 hasAuthorship W2018544486A5032715968 @default.
- W2018544486 hasAuthorship W2018544486A5054635684 @default.
- W2018544486 hasAuthorship W2018544486A5056818066 @default.
- W2018544486 hasAuthorship W2018544486A5061789027 @default.
- W2018544486 hasAuthorship W2018544486A5064798164 @default.
- W2018544486 hasAuthorship W2018544486A5069079748 @default.
- W2018544486 hasAuthorship W2018544486A5075947127 @default.
- W2018544486 hasAuthorship W2018544486A5084429665 @default.
- W2018544486 hasBestOaLocation W20185444861 @default.
- W2018544486 hasConcept C101762097 @default.
- W2018544486 hasConcept C104317684 @default.
- W2018544486 hasConcept C119056186 @default.
- W2018544486 hasConcept C134320426 @default.
- W2018544486 hasConcept C145059251 @default.
- W2018544486 hasConcept C150194340 @default.
- W2018544486 hasConcept C171958077 @default.
- W2018544486 hasConcept C2778923194 @default.
- W2018544486 hasConcept C39845236 @default.
- W2018544486 hasConcept C502942594 @default.
- W2018544486 hasConcept C54355233 @default.
- W2018544486 hasConcept C62478195 @default.
- W2018544486 hasConcept C86803240 @default.
- W2018544486 hasConcept C95444343 @default.
- W2018544486 hasConceptScore W2018544486C101762097 @default.
- W2018544486 hasConceptScore W2018544486C104317684 @default.
- W2018544486 hasConceptScore W2018544486C119056186 @default.
- W2018544486 hasConceptScore W2018544486C134320426 @default.
- W2018544486 hasConceptScore W2018544486C145059251 @default.
- W2018544486 hasConceptScore W2018544486C150194340 @default.
- W2018544486 hasConceptScore W2018544486C171958077 @default.
- W2018544486 hasConceptScore W2018544486C2778923194 @default.
- W2018544486 hasConceptScore W2018544486C39845236 @default.
- W2018544486 hasConceptScore W2018544486C502942594 @default.
- W2018544486 hasConceptScore W2018544486C54355233 @default.